Mastodawn

GastroAGI 7h ago

Recurrent dysphagia after esophageal SEMS?
👉 Don’t assume tumor progression.

📸 X-ray: Stent migrated into stomach

💡 Most common cause: stent migration

🔧 Next step:
✔ Endoscopy
✔ Retrieval ± re-stenting (better fixation)

🎯 Restore swallowing, improve QOL

#EsophagealCancer #GI #Endoscopy #Oncology #Dysphagia #GastroAGI

unitedvrg.com 19h ago

Beam’s Eye View Imaging in Radiation Oncology (2017) by Ross I. Berbeco, Ph.D.
Author: Ph.D.
File Type: PDF
Download at https://unitedvrg.com/2023/05/13/pdf-beams-eye-view-imaging-in-radiation-oncology-2017-by-ross-i-berbeco-ph-d/
#Oncology&Hematology, #Ph.D.

MedBridgeNZ 23h ago

Exploring global oncology pathways? In 2025, China approved a record 120 new drugs, expanding access to advanced cancer therapies. As a specialized medical concierge provider, MedBridgeNZ helps international patients safely navigate Medical Tourism China. Read our 2026 guide: https://zurl.co/6b1Z2
#Oncology #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism

Accessing Advanced Cancer Therapies in China: 2026 Guide

Home > Blog > Advanced Therapies & TechnologyKey Takeaways • In 2025, China's National Medical Products Administration (NMPA) approved a record 120 new drugs, including 76 innovative therapies and 11 First-in-Class molecules. • Novel VHH-based CAR-T therapies (such as IMC002 targeting CLDN18.2) are demonstrating substantial objective response rates in clinical trials for advanced gastrointestinal cancers. • Effective May 2026, the new "Regulations on the Administration of Clinical Research and C

Medbridge Nz

Scientific Frontline 1d ago

Researchers have identified composite blood biomarkers—specific combinations of proteins and metabolites—that can reliably detect early stages of colorectal, lung, and ovarian cancers.
#Oncology #Proteomics #Metabolomics #Pathology #sflorg
https://www.sflorg.com/2026/04/ongy04202601.html

New biomarkers for detecting cancer

Biomarkers in the blood could be used for the early detection of colorectal cancer, lung cancer and ovarian cancer.

unitedvrg.com 2d ago

Breast Cancer: Diagnostic Imaging and Therapeutic Guidance (2017) by Uwe Fischer and Friedemann Baum
Author: Breast Cancer
File Type: PDF
Download at https://unitedvrg.com/2023/02/14/pdf-breast-cancer-diagnostic-imaging-and-therapeutic-guidance-2017-by-uwe-fischer-and-friedemann-baum/
#Oncology&Hematology, #BreastCancer

All Scientifical 2d ago

What steps can be taken to reduce the risk of cancer? #oncology #cancer #cancerriskfactors #tumores ... Continue to: https://www.facebook.com/reel/2486088441840197/

MedBridgeNZ 2d ago

Facing long waitlists for advanced cancer care? Discover how international patients access world-class Proton & Heavy Ion Therapy in Shanghai. As a dedicated medical concierge provider (managing logistics, not medical treatments), MedBridgeNZ is your trusted bridge for Medical Tourism China.

Read the full guide on costs, top hospitals, and access here:
https://zurl.co/86UAP

#ProtonTherapy #HeavyIonTherapy #Oncology #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism

Proton & Heavy Ion Therapy in China: Costs & Hospitals

Home > Blog > Advanced Therapies & TechnologyKey Takeaways • Targeted Precision: Particle therapy utilizes the "Bragg Peak" effect to deliver concentrated radiation doses precisely at the tumor site, significantly reducing exit dose and minimizing damage to surrounding healthy tissues. • Cost and Efficiency: While Western facilities face severe waitlist crises, accessing treatment in China can offer high-throughput availability and comprehensive treatment packages estimated between $45,000 and $

Medbridge Nz

Jack C.M 3d ago

AI identifies early risk patterns for skin cancer. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🤖 🧠 #MedicalScience 💉💊🏥🩸😷 #Oncology

AI identifies early risk patte...

AI identifies early risk patterns for skin cancer

A massive Swedish study shows that AI can spot people at higher risk of melanoma using routine health data. Advanced models significantly outperformed basic methods, identifying high-risk groups with striking accuracy. Some individuals flagged by the system had up to a 33% chance of developing melanoma within five years. This approach could pave the way for smarter, more targeted screening.

ScienceDaily